Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1854752
Reference Type
Journal Article
Title
Terbinafine-induced fixed drug eruption with the characteristic distribution of "Baboon-Syndrome"
Author(s)
Weiss, JM; Mockenhaupt, M; Schopf, E; Simon, JC
Year
2001
Is Peer Reviewed?
Yes
Journal
Der Hautarzt
ISSN:
0017-8470
EISSN:
1432-1173
Volume
52
Issue
12
Page Numbers
1104-1106
Language
German
PMID
11910862
DOI
10.1007/s001050170022
Web of Science Id
WOS:000173039500007
Abstract
A 26 year old patient developed a fixed drug eruption located on his hands, inguinal and gluteal areas following oral treatment of onychomycosis with terbinafine. The rash showed the characteristic distribution of the "baboon-syndrome", so-named because of the red perianal region of the baboon. Although epicutaneous testing revealed no positive reaction, the rash could be induced in identical sites by oral administration of terbinafine. As the underlying pathomechanism for the "baboon-syndrome" a systemically induced allergic contact dermatitis has been suggested. In addition to the described substances, e.g. mercury, amoxicillin, ampicillin, heparin and nickel, this is the first report of "baboon syndrome" induced by terbinafine.
Keywords
baboon syndrome; fixed drug eruption; terbinafine
Tags
IRIS
•
Methylmercury
ADME Search: Jan 1990 - Nov 2018
Results with mercury
PubMed
WoS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity